[HTML][HTML] Global landscape review of serotype-specific invasive pneumococcal disease surveillance among countries using PCV10/13: the pneumococcal serotype …
…, MK Hetrich, Y Yang, JN Sinkevitch, K Ampofo… - Microorganisms, 2021 - mdpi.com
Serotype-specific surveillance for invasive pneumococcal disease (IPD) is essential for
assessing the impact of 10- and 13-valent pneumococcal conjugate vaccines (PCV10/13). The …
assessing the impact of 10- and 13-valent pneumococcal conjugate vaccines (PCV10/13). The …
[HTML][HTML] Binding and neutralizing antibody responses to SARS-CoV-2 in very young children exceed those in adults
…, EA Schappell, SD Schmidt, MD Knoll, MK Hetrich… - JCI insight, 2022 - ncbi.nlm.nih.gov
Background SARS-CoV-2 infections are frequently milder in children than adults, suggesting
that immune responses may vary with age. However, information is limited regarding SARS-…
that immune responses may vary with age. However, information is limited regarding SARS-…
Assessment of clinical and virological characteristics of SARS-CoV-2 infection among children aged 0 to 4 years and their household members
…, K Guenther, K Herbert, M Jordan, K Loehr… - JAMA Network …, 2022 - jamanetwork.com
Importance Few studies have prospectively assessed SARS-CoV-2 community infection in
children aged 0 to 4 years. Information about SARS-CoV-2 incidence and clinical and …
children aged 0 to 4 years. Information about SARS-CoV-2 incidence and clinical and …
[HTML][HTML] Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 following Introduction of PCV10 and PCV13: Findings from …
JC Bennett, MK Hetrich, M Garcia Quesada… - Microorganisms, 2021 - mdpi.com
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal
disease (IPD) globally before the introduction of pneumococcal conjugate vaccines (…
disease (IPD) globally before the introduction of pneumococcal conjugate vaccines (…
Epidemiology of Human Parainfluenza Virus Type 3 and Respiratory Syncytial Virus Infections in the Time of Coronavirus Disease 2019: Findings From a Household …
MK Hetrich, J Oliva, K Wanionek… - Clinical Infectious …, 2023 - academic.oup.com
… Marissa K Hetrich , Marissa K Hetrich … Marissa K Hetrich, Jennifer Oliva, Kimberli Wanionek,
Maria Deloria Knoll, Matthew Lamore, Ignacio Esteban, Vic Veguilla, Fatimah S Dawood, …
Maria Deloria Knoll, Matthew Lamore, Ignacio Esteban, Vic Veguilla, Fatimah S Dawood, …
Impact of age and symptom development on SARS-CoV-2 transmission in households with children—Maryland, New York, and Utah, August 2020–October 2021
…, E Schappell, MK Hetrich… - Open Forum …, 2022 - academic.oup.com
Background Households are common places for spread of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). We investigated factors associated with household …
syndrome coronavirus 2 (SARS-CoV-2). We investigated factors associated with household …
[HTML][HTML] Epidemiology of Human Parainfluenza Virus Type 3 and Respiratory Syncytial Virus Infections in the Time of Coronavirus Disease 2019: Findings From a …
MK Hetrich, J Oliva, K Wanionek, MD Knoll… - Clin Infect …, 2023 - pesquisa.bvsalud.org
BACKGROUND: During the coronavirus disease 2019 (COVID-19) pandemic, human
parainfluenza type 3 (HPIV-3) and respiratory syncytial virus (RSV) circulation increased as …
parainfluenza type 3 (HPIV-3) and respiratory syncytial virus (RSV) circulation increased as …
Early, robust mucosal secretory IgA but not IgG response to SARS-CoV-2 spike in oral fluid is associated with faster viral clearance and COVID-19 symptom resolution
…, AAR Antar, MK Hetrich, ZO Demko, X Zhang, K Spicer… - medRxiv, 2024 - medrxiv.org
High priority efforts are under way to support the development of novel mucosal COVID-19
vaccines, such as the US Government′s Project NextGen and the Center for Epidemic …
vaccines, such as the US Government′s Project NextGen and the Center for Epidemic …
Global Impact of 10-and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in All Ages: The PSERENADE Project
…, M Garcia Quesada, SL Zeger, MK Hetrich… - 2024 - papers.ssrn.com
Background: Approximately ten years after seven-valent pneumococcal conjugate vaccine (PCV7)
was licensed, PCV10 and PCV13 became available. We evaluated their impacts …
was licensed, PCV10 and PCV13 became available. We evaluated their impacts …
Binding and neutralizing antibody responses to SARS-CoV-2 in infants and young children exceed those in adults
…, EA Schappell, SD Schmidt, MD Knoll, MK Hetrich… - medRxiv, 2021 - medrxiv.org
SARS-CoV-2 infections are frequently milder in children than adults, suggesting that
immune responses may vary with age. However, information is limited regarding SARS-CoV-2 …
immune responses may vary with age. However, information is limited regarding SARS-CoV-2 …